Friday, 28 January, 2022
TopicSputnik V

Topic: Sputnik V

Sputnik maker wages Twitter war over ‘low efficacy’ of mRNA vaccines, says its booster can help

Sputnik cites pre-print papers, claims its vaccine produces longer efficacy compared to mRNA vaccines like Pfizer or Moderna.

Slow-growing second dose virus delays Sputnik V’s entry into India’s govt vaccination drive

Sputnik V was given clearance by the Drugs Controller General of India (DCGI) in April. It is currently available at some private facilities.

India to have 18-22 crore vaccine doses by September, ZyCoV D could take longer to hit market

The increase in vaccine procurement is good news in terms of daily vaccination numbers, but govt's stated target of 1 crore daily vaccinations still some time away.

15 crore vaccine doses expected in August delays plan of 1 crore daily shots

Talks are still on with Moderna, Sputnik yet to be procured for the national Covid vaccination programme, which means Covishield and Covaxin will remain the mainstay.

SII to begin manufacturing Sputnik V in India by September, targets 300 million doses a year

Pune-based vaccine manufacturer SII has already received cell and vector samples for the production of Sputnik V from Russia's Gamaleya Center, the developer of the vaccine.

Morepen Labs in Himachal begins production of Sputnik V’s test batch

Russia's RDIF has also reached agreements with other pharmaceutical companies in India including Gland Pharma, Hetero Biopharma, Panacea Biotec, Stelis Biopharma & Virchow Biotech.

Fortis, Apollo begin administering Sputnik V vaccines at 2 hospitals in Delhi-NCR

The two doses of Sputnik V vaccines are not interchangeable and given 21 days apart. The Centre has fixed the price at Rs 1,145 per dose.

Full launch of Sputnik V vaccine in India could take more time, says Dr Reddy’s

Dr Reddy's, through which Russia's Sputnik V is available in India, said the timeline was pushed a little further due to import dependency, quality checks.

WHO team flags concerns over Sputnik V filling plant in Russia, firm claims issues addressed

Dr Reddy's Laboratories is in a pact with Russian Direct Investment Fund to sell the first 250 million vials of Sputnik V in India. It has already received nearly 3 million doses.

DCGI grants permission to Serum Institute to manufacture Sputnik V in India

The permission has been granted for examination, test and analysis of the Sputnik vaccine at SII's licensed Hadapsar facility under certain conditions, official sources said.

On Camera


Apple needs to break out of its comfort zone with bold mega deals à la Microsoft

Historically, large M&A hasn’t been Apple’s style. However, with its resources, the company can certainly take the risk to transform its business and expand its capabilities.

Google to pour Rs 7,500 crore in Bharti Airtel to boost India push, will buy 1.28% stake

Alphabet, which owns the Google search engine, will pay Rs 5,250 crore for a stake in Airtel. Another Rs 2,000 crore will go toward multi-year plans that will include devices.


The Indian Army's Akash missiles on display during the 73rd Republic Day Parade, at Rajpath, in New Delhi | ANI

Not just 1st R-Day, 26 Jan 1950 also significant as Indian Army, Navy shed ‘Royal’ prefix

Both the ‘Royal’ prefix for the Navy and Air Force in India, as well as the absence of such a label for the Army, have their roots in British military and political history.

Modi vs non-BJP CMs: When most popular isn’t all-powerful & why Centre-state ties will worsen

Modi’s inability to win many states, and the huge popularity his rivals enjoy there, is pushing Indian politics in a more robustly federal direction.